Unknown

Dataset Information

The effect of PTC124 on choroideremia fibroblasts and iPSC-derived RPE raises considerations for therapy.


ABSTRACT: Inherited retinal dystrophies (IRDs) are caused by mutations in over 200 genes, resulting in a range of therapeutic options. Translational read-through inducing drugs (TRIDs) offer the possibility of treating multiple IRDs regardless of the causative gene. TRIDs promote ribosomal misreading of premature stop codons, which results in the incorporation of a near-cognate amino acid to produce a full-length protein. The IRD choroideremia (CHM) is a pertinent candidate for TRID therapy, as nonsense variants cause 30% of cases. Recently, treatment of the UAA nonsense-carrying CHM zebrafish model with the TRID PTC124 corrected the underlying biochemical defect and improved retinal phenotype. To be clinically relevant, we studied PTC124 efficiency in UAA nonsense-carrying human fibroblasts and ind

SUBMITTER: Torriano S 

PROVIDER: S-EPMC5974348 | biostudies-literature | 2018 May

REPOSITORIES: biostudies-literature